Bayer: all 1,694 studies
Page 8 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- An Evaluation of a Customized Insole to Provide Relief From Heel Pain Due to Plantar Fasciitis or General Heel Pain When Used in Footwear Over a Period of Four WeeksCompletedNCT03507478Not applicable
- First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express MesothelinCompletedNCT03507452Phase 1
- Study to Evaluate the QT / QTc Interval Prolongation Potential of VericiguatCompletedNCT03504982Phase 1
- Copanlisib Chinese PK StudyCompletedNCT03498430Phase 1
- Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding PatternCompletedNCT03493295
- A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With PsoriasisCompletedNCT03493269Phase 1
- Rogaratinib (BAY1163877) Human Mass Balance StudyCompletedNCT03484585Phase 1
- Association Between the Prevalence of Cardiovascular Risk Factors and New Use of TestosteroneCompletedNCT03484260
- A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe HemophiliaCompletedNCT03481946Phase 1
- A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual BleedingTerminatedNCT03476928Phase 3
- Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian DatabasesCompletedNCT03474757
- A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin AmericaCompletedNCT03470103
- Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists EventsCompletedNCT03462446
- Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)CompletedNCT03455439
- A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen ExposureCompletedNCT03443843Phase 4
- In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's ControlCompletedNCT03441568Not applicable
- BAY2328065 Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Relative Bioavailability, Food EffectCompletedNCT03427788Phase 1
- A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed ConditionsCompletedNCT03424135Phase 1
- Multi-academic Center Study of Xofigo PatientsCompletedNCT03419442
- A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis SubjectsCompletedNCT03418168Phase 3
- A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney DiseaseCompletedNCT03412006Phase 2
- Pharmacokinetics and Safety of Vilaprisan in Renal ImpairmentCompletedNCT03411980Phase 1
- Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD)CompletedNCT03411941
- Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in ChinaCompletedNCT03410706
- Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1bCompletedNCT03408093
- Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement TherapiesCompletedNCT03405337
- A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid MalignanciesTerminatedNCT03404726Phase 1
- Renal Impairment StudyCompletedNCT03402438Phase 1
- 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratCompletedNCT03399526Phase 1
- A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult SubjectsCompletedNCT03396250Phase 1
- Metastatic Colorectal Cancer Patients With Long-term Response to RegorafenibCompletedNCT03386825
- Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration PatientsCompletedNCT03382587
- Rivaroxaban vs Warfarin for SPAF in Multi-morbid PatientsCompletedNCT03374540
- A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work BestTerminatedNCT03373422Phase 2
- BAY94-9027 PK Study Comparing to Another Long Acting ProductCompletedNCT03364998Phase 1
- Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal DysfunctionCompletedNCT03359876
- Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and MidazolamCompletedNCT03353857Phase 1
- A Study of Molidustat for Correction of Renal Anemia in Dialysis SubjectsCompletedNCT03351166Phase 3
- A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis SubjectsCompletedNCT03350347Phase 3
- A Study of Molidustat for Correction of Renal Anemia in Non-dialysis SubjectsCompletedNCT03350321Phase 3
- Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mgCompletedNCT03350295Phase 1
- Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsCompletedNCT03349684Phase 3
- Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCCCompletedNCT03347292Phase 1
- Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is PlannedTerminatedNCT03342859Phase 1
- Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits StudyCompletedNCT03334838Phase 1
- Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review StudyWithdrawnNCT03325127
- Treatment Satisfaction With Ra-223 in JapanCompletedNCT03315260
- Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in SwedenCompletedNCT03311139
- Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough PatientsCompletedNCT03310645Phase 1/2
- Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial HypertensionCompletedNCT03293407
- Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical PracticeCompletedNCT03290794
- Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)CompletedNCT03289273
- Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial FibrillationCompletedNCT03284762
- The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical SettingCompletedNCT03278262
- FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedNCT03276143Phase 2
- BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up StudiesCompletedNCT03269175Phase 4
- Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease PatientsCompletedNCT03255512Phase 1
- Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male SubjectsCompletedNCT03252002Phase 1
- Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With MethotrexateCompletedNCT03244462Phase 1
- Real-world Dosing Patterns of Rivaroxaban in the United StatesCompletedNCT03242278
- A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine FibroidsTerminatedNCT03240523Phase 3
- Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male VolunteersCompletedNCT03237416Phase 1
- Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy SubjectsCompletedNCT03235076Phase 1
- A Study to Assess Disintegration of the New Aspirin Disintegrating TabletsCompletedNCT03225352Phase 1
- A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat CancerCompletedNCT03215511Phase 1
- Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With RivaroxabanCompletedNCT03214172
- BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food EffectCompletedNCT03212586Phase 1
- Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)CompletedNCT03210246Phase 1
- Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene FusionNo longer availableNCT03206931
- Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational StudyCompletedNCT03194633
- First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and LymphomasCompletedNCT03188965Phase 1
- KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive MethodCompletedNCT03182140
- A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their DiseaseCompletedNCT03161912
- Relative Bioavailability and Food Effect Study With Vericiguat to Characterize the Pediatric Formulation in Adult Healthy SubjectsCompletedNCT03145038Phase 1
- Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.CompletedNCT03136666Phase 1
- Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot StudyCompletedNCT03134573
- The Effects of BAY1193397 on Skin Capillary Blood Flow and Transcutaneous Oxygen PressureCompletedNCT03128320Phase 2
- BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)CompletedNCT03127735Phase 1
- A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in RussiaCompletedNCT03126773
- Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or DysmenorrheaCompletedNCT03126747
- Use of Direct Oral Anticoagulants in UKCompletedNCT03119116
- Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116TerminatedNCT03119077Phase 1
- Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid TumorsCompletedNCT03102320Phase 1
- Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)CompletedNCT03092999Phase 1
- Bioequivalence Study of BAY 77-1931 Orally Disintegrating TabletCompletedNCT03074058Phase 1
- LCS16 vs. COC User Satisfaction and Tolerability StudyCompletedNCT03074045Phase 3
- Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin TabletsCompletedNCT03056703Phase 1
- First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845CompletedNCT03054402Phase 1
- Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or InductionCompletedNCT03048110Phase 1
- Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene FusionApproved for marketingNCT03025360
- Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016)CompletedNCT03012347Not applicable
- Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)CompletedNCT03002922Not applicable
- Sun Protection Factor Assay (344/2016)CompletedNCT02995161Not applicable
- Sun Protection Factor Assay (343/2016)CompletedNCT02995148Not applicable
- Sun Protection Factor Assay (341/2016)CompletedNCT02995135Not applicable
- Sun Protection Factor Assay (339/2016)CompletedNCT02995122Not applicable
- Sun Protection Factor Assay (338/2016)CompletedNCT02995109Not applicable
- Sun Protection Factor Assay (319/2016)TerminatedNCT02995044Not applicable
- Sun Protection Factor Assay (318/2016)TerminatedNCT02995031Not applicable
- Sun Protection Factor Assay (317/2016)CompletedNCT02995018Not applicable